author-photo

Takehiro Yatomi

Mochida Pharmaceutical Co., Ltd

11

Papers

663

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Lack of Correlation Between Clinical Characteristics and Serum Soluble Fas Ligand Levels in Patients with Multiple Myeloma

2001 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)
Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis : relationship with soluble Fas, tumor necrosis factor α and TNF receptor-1

2000 Hepatology Research
Show All
- Source
- Cite
- Save
Citations (7)
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.

1999 Journal of Clinical Investigation
Show All
- Source
- Cite
- Save
Citations (334)
Acute Toxicity of an Anti-Fas Antibody in Mice

1999 Toxicologic Pathology
Show All
- Source
- Cite
- Save
Citations (29)
Means for prevention / treatment of inflammatory bowel disease

1999
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease.

1999 International Immunology
Show All
- Source
- Cite
- Save
Citations (61)
Increased Serum Soluble Fas Ligand Associated with Recurrent B-Cell Non-Hodgkin's Lymphoma after Autologous Peripheral Blood Stem Cell Transplantation

1999 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (9)
Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-versus-host disease.

1998 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (60)
Fas antagonist FOR THE PREVENTION AND TREATMENT OF GVHD

1997
Show All
- Source
- Cite
- Save
Citations (0)
Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes.

1997 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (159)